659 research outputs found

    Anatomy of the differential gluon structure function of the proton from the experimental data on F_2p

    Get PDF
    The use of the differential gluon structure function of the proton F(x,Q2){\cal F}(x,Q^{2}) introduced by Fadin, Kuraev and Lipatov in 1975 is called upon in many applications of small-x QCD. We report here the first determination of F(x,Q2){\cal F}(x,Q^{2}) from the experimental data on the small-x proton structure function F2p(x,Q2)F_{2p}(x,Q^{2}). We give convenient parameterizations for F(x,Q2){\cal F}(x,Q^{2}) based partly on the available DGLAP evolution fits (GRV, CTEQ & MRS) to parton distribution functions and on realistic extrapolations into soft region. We discuss an impact of soft gluons on various observables. The x-dependence of the so-determined F(x,Q2){\cal F}(x,Q^{2}) varies strongly with Q^2 and does not exhibit simple Regge properties. None the less the hard-to-soft diffusion is found to give rise to a viable approximation of the proton structure function F_{2p}(x,Q^2) by the soft and hard Regge components with intercepts \Delta_{soft}=0 and \Delta_{hard}\sim 0.4.Comment: 37 pages, 25 figure

    Color mixing in high-energy hadron collisions

    Get PDF
    The color mixing of mesons propagating in a nucleus is studied with the help of a color-octet Pomeron partner present in the two-gluon model of the Pomeron. For a simple model with four meson-nucleon channels, color mixings are found to be absent for pointlike mesons and very small for small mesons. These results seem to validate the absorption model with two independent color components used in recent analyses of the nuclear absorption of J/ψJ/\psi mesons produced in nuclear reactions.Comment: 3 journal-style page

    Role of brain natriuretic peptide in the pathogenesis of resistant hypertension

    Get PDF
    Modern medicine has successfully used the N-terminal pro-brain natriuretic peptide (NT-proBNP) as a biomarker for many cardiovascular diseases (CVDs). According to a number of studies, NT-proBNP may also play a role in the development of resistant hypertension (RH), but the existing work addresses this issue only indirectly. In turn, RH causes serious damage to the economic and social spheres, worsening the quality of life of patients. Thus, the complexity of verification and treatment of RH, the inconsistency of the described associations of NT-proBNP and RH makes this topic more relevant than ever

    Interaction of Wilson loops in confining vacuum

    Get PDF
    Nonperturbative and perturbative interaction mechanisms of Wilson loops in gluodynamics are studied within the background field formalism. The first one operates when distance between minimal surfaces of the loops is small and may be important for sea quark effects and strong decay processes. The second mechanism -- perturbative interaction in nonperturbative confining background is found to be physically dominant for all loop configurations characteristic of scattering process. It reduces to perturbative gluon exchanges at small distances, while at larger distances it corresponds to the t-channel exchange of (reggeized) glueball states. Comparison to other approaches is made and possible physical applications are discussed.Comment: LaTeX, 25 pages, 5 EPS-figure

    The QCD description of diffractive processes

    Get PDF
    We review the application of perturbative QCD to diffractive processes. We introduce the two gluon exchange model to describe diffractive qq(bar) and qq(bar)g production in deep inelastic scattering. We study the triple Regge limit and briefly consider multiple gluon exchange. We discuss diffractive vector meson production at HERA both at t = 0 and large |t|. We demonstrate the non-factorization of diffractive processes at hadron colliders.Comment: 39 pages, 14 figures, LaTeX, new references added and some discussion clarifie

    C-reactive protein as an indicator of polymorbidity in patients with arterial hypertension

    Get PDF
    Aim of the study was to investigate the role of C-reactive protein as an indicator of multimorbidity in patients with arterial hypertension.Material and methods. A retrospective archival study of the data of 1958 patients with arterial hypertension who were examined and treated at the clinic of the Federal Research Center for Fundamental and Translational Medicine (Novosibirsk) was carried out. 2 groups of patients were allocated depending on the concentration of C-reactive protein in the blood serum: normal and elevated (> 5 mg/l). A comparative analysis of the severity of polymorbidity, as well as clinical, laboratory and biochemical parameters in the selected groups were carried out.Results. It has been established that patients with arterial hypertension with elevated values of C-reactive protein had higher rates of transnosological and transsystemic polymorbidity, accompanied by changes in lipid, carbohydrate and purine metabolism (a decrease in high-density lipoprotein cholesterol, an increase in the concentration of glucose and uric acid in blood serum, an increase in the index atherogenicity), as well as an increase in the content of fibrinogen in the blood serum.Conclusions. The concentration of C-reactive protein in the blood serum can serve as a biochemical marker of polymorbidity in patients with arterial hypertension

    Multiparton interactions and production of minijets in high energy hadronic collisions

    Get PDF
    We discuss the inclusive cross section to produce two minijets with a large separation in rapidity in high energy hadronic collisions. The contribution to the inclusive cross section from the exchange of a BFKL Pomeron is compared with the contribution from the exchange of two BFKL Pomerons, which is induced by the unitarization of the semi-hard interaction. The effect of the multiple exchange is studied both as a function of the azimuthal correlation and as a function of the transverse momentum of the observed minijets.Comment: TeX file, 20 pages, 4 figures available on reques

    Risk factors in patients with non-alcoholic fatty liver disease associated with arterial hypertension, overweight and obesity

    Get PDF
    Purpose of the study was to investigate the features of the occurrence of risk factors in patients with non-alcoholic fatty liver disease associated with arterial hypertension, overweight and obesity.Material and methods. The object of the study was the data of 14 393 case histories of patients with arterial hypertension (AH), non-alcoholic fatty liver disease (NFLD), overweight body (OB) and obesity, examined and treated at the clinic of the Federal Research Center forFundamental and Translational Medicine (Novosibirsk).Results and discussion. Features of biochemical parameters in patients with NFLD with AH, OB and obesity were studied in comparison with patients with isolated diseases. It was shown that in patients, in case of the presence of this comorbidity, the value of transsystem polymorbidity is statistically significantly increased compared with groups of patients with isolated diseases. It was established that patients with concomitant diseases have higher, statistically significant values of systolic and diastolic blood pressure, body mass index. They have higher concentrations of total cholesterol, triglycerides, high density lipoprotein cholesterol, glucose, uric acid in the blood serum, higher atherogenic index. A study of the frequency of occurrence of risk factors in the groups showed the highest frequency values in patients with associated diseases: high blood pressure, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, hypoalphacholesterolemia, hyperlipidemia, increased atherogenic index, hyperglycemia, hyperuricemia, the higher levels of C-reactive protein, which indicates that with associated pathology, changes in carbohydrate, lipid and purine metabolism are more pronounced. These changes are factors that aggravate the course of the pathology and are risk factors for the development of diabetes mellitus, atherosclerosis and associated conditions, which requires a personalized approach to the treatment and prevention of this category of patients. The results of this study can form the basis for the development of new medical technology for assessing the severity of condition in patients with non-alcoholic fatty liver disease combined with arterial hypertension, overweight and obesity
    corecore